AI aims to make smarter, safer choices for heart, cancer, and sepsis care

NCT ID NCT06694181

Recruiting now Knowledge-focused Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is developing and testing artificial intelligence (AI) tools to help doctors make personalized decisions for patients with heart disease, breast cancer, or sepsis. The AI will be designed to explain its recommendations clearly and ensure safety. Researchers will use data from up to 300,000 patients at Penn Medicine hospitals to train and evaluate these AI systems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to AI systems that help doctors make safer, more personalized treatment decisions for heart disease, breast cancer, and sepsis.
What could go wrong: This is an early-stage study focused on developing and testing AI algorithms, not a treatment trial. It may not result in immediate clinical changes, and the AI recommendations will need further validation before widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICAL INTELIGENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm infectious disease with sepsis invasive breast carcinoma Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICAL INTELIGENCE BREAST CANCER CARDIOLOGY SEPSIS

Contacts and locations

Locations

Hospital of the University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.